• Produktart

    Anlageklasse

    Anlagefokus

  • Wissen
  • Wie investieren

  • Wir stellen uns vor

    Betrugsprävention""
    • FTSE 100 UCITS ETF

    FTSE 100 UCITS ETF - (GBP) Distributing (VUKE)

    Dokumente
    ""

    Legen Sie einen Sparplan an oder tätigen Sie eine Einmalanlage

    Jetzt über einen Online-Broker investieren

    Mehr erfahren

    Fondsinformationen

    Ziele und Anlagepolitik

    • Der Fonds verfolgt einen Passivmanagement- bzw. Indexierungsanlageansatz, indem er Wertpapiere physisch erwirbt und versucht, die Wertentwicklung des FTSE 100 Index (der „Index“) nachzubilden.
    • Der Index besteht aus Aktien von großen Unternehmen in Großbritannien.
    • Der Fonds versucht: 1. die Wertentwicklung des Index nachzubilden, indem er in alle im Index enthaltenen Wertpapiere im gleichen Verhältnis wie im Index investiert. Wenn eine vollständige Replikation nicht möglich ist, verwendet der Fonds ein Nachbildungsverfahren. 2. vollständig investiert zu bleiben, außer bei außergewöhnlichen Markt-, politischen oder ähnlichen Bedingungen.

    Fondsdaten

    Auflegung der Anteilsklasse
    22. Mai 2012
    Notierungsdatum
    23. Mai 2012
    Anlagestruktur
    Irish UCITS
    Volumen der Anteilsklasse
    Fondsvolumen
    Risikoindikator
    Strategie
    Vergleichsindex
    Assetklasse
    Aktien
    Anlagemethode
    Physisch
    Index-Ticker
    UKXNUK
    Vergleichsindex
    FTSE 100 Index
    Dividend schedule
    Vierteljährlich
    Steuerlicher Status
    Reporting für Österreich, Deutschland, Schweiz und Vereinigtes Königreich
    Vermögensverwalter

    Vanguard Asset Management, Limited

    Domizil
    Irland
    Rechtsform
    Vanguard Funds PLC

    Der Wert von Anlagen und die daraus resultierenden Erträge können steigen oder fallen, und Investoren können Verluste auf ihre Investitionen erleiden.

    Der Fonds ist nach dem InvStG 2018 als Aktienfonds klassifiziert und hat eine Mindestkapitalbeteiligungsquote von 80.00%

    Wertentwicklung

    Risiko und Volatilität

    Per 31. Aug. 2026

    Beta
    R-Quadrat
    Annualisierter Tracking Error
    1 Jahr
    3 Jahre
    5 Jahre

    Bitte beachten Sie, dass Angaben zum Beta und zum Bestimmheitsmaß nur für Fonds vorliegen, die seit mindestens drei vollen Jahren existieren.

    Der Wert von Anlagen und die daraus resultierenden Erträge können steigen oder fallen, und Investoren können Verluste auf ihre Investitionen erleiden.

    Portfoliodaten

    Fondsmerkmale
    FundamentaldatenFondsVergleichsindexPer
    Anzahl Aktien 102 100 31. Aug. 2026
    Marktkapitalisierung (Median) 67.1 B 67.1 B 31. Aug. 2026
    15.6 x 15.6 x 31. Aug. 2026
    2.3 x 2.3 x 31. Aug. 2026
    11.9% 11.9% 31. Aug. 2026
    8.8% 8.8% 31. Aug. 2026
    Umschlagshäufigkeit -19.1% — 30. Juni 2026

    Marktallokation

    Per 31. Aug. 2026

    LandRegionFondsVergleichsindexVarianz +/-
    Vereinigtes KönigreichEuropa 99.81% 100.00% -0.19%
    Guernsey, C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I., C.I.Europa 0.19% — —

    Aufschlüsselung der Positionen

    Per 31. Aug. 2026

    Wertpapiere% der AssetsSektorRegionMarktwertAnteile
    HSBC Holdings PLC 10.03784% Financials GB £ 671'570'813.63 43'939'467
    Shell PLC 7.18533% Energy GB £ 480'727'058.70 14'373'660
    AstraZeneca PLC 6.87130% Health Care GB £ 459'716'588.10 3'840'573
    Rolls-Royce Holdings PLC 4.91457% Industrials GB £ 328'804'295.74 21'487'668
    Unilever PLC 3.85463% Consumer Staples GB £ 257'889'528.72 5'399'697
    British American Tobacco PLC 3.20838% Consumer Staples GB £ 214'653'166.88 5'198'672
    BP PLC 3.08945% Energy GB £ 206'696'253.86 40'174'199
    Rio Tinto PLC 3.03983% Basic Materials GB £ 203'376'731.70 2'650'205
    GSK PLC 2.82993% Health Care GB £ 189'333'671.95 10'214'927
    Barclays PLC 2.59343% Financials GB £ 173'510'870.73 34'936'247

    In der prozentualen Aufschlüsselung der Allokation sind Bar- und Futurepositionen nicht angegeben, außerdem werden die Beträge gerundet, oder Bargeld und/oder Derivate nicht mitgerrechnet. Daher kann es sein, dass die Summe nicht genau 100% ergibt. 

    Der Wert von Anlagen und die daraus resultierenden Erträge können steigen oder fallen, und Investoren können Verluste auf ihre Investitionen erleiden.

    Die gewichteten Aktienpositionen schließen alle vorübergehenden Barinvestitionen und Aktienindex-Derivate aus.

    Preise & Ausschüttungen

    Preise

    Nettovermögenswert (GBP)
    £ 45.63
    GBP
    Veränderung
    +£ 0.481.06%
    Per 09. Okt. 2026
    Marktwert (CHF)
    CHF 50.31
    Veränderung
    +CHF 0.651.31%
    Per 09. Okt. 2026
    NAV (52-Wochen-Hoch)
    £ 47.42
    Per 11. Okt. 2026
    Marktwert (52-Wochen-Hoch)
    CHF 51.96
    Per 11. Okt. 2026
    NAV (52-Wochen-Tief)
    £ 40.55
    Per 11. Okt. 2026
    Marktwert (52-Wochen-Tief)
    CHF 43.30
    Per 11. Okt. 2026
    NAV Differenz 52 Wochen
    £ 6.86
    Veränderung
    +14.47%
    Per 11. Okt. 2026
    Marktwert Differenz 52 Wochen
    CHF 8.66
    Veränderung
    +16.67%
    Per 11. Okt. 2026
    Ausstehende Anteile
    100'196'719
    Per 30. Sept. 2026
    Historische Kurse

    -

    Auflegungsdatum

    22. Mai 2012

    Notierungsdatum

    26. Apr. 2017

    Daten NAV (GBP) Marktpreis (CHF)
    09. Okt. 2026 £ 45.6337 CHF 50.3100
    08. Okt. 2026 £ 45.1562 CHF 49.6600
    07. Okt. 2026 £ 45.2260 CHF 49.8250
    06. Okt. 2026 £ 45.5857 CHF 50.5300
    05. Okt. 2026 £ 45.3964 CHF 49.7700
    02. Okt. 2026 £ 45.2412 CHF 49.9600
    01. Okt. 2026 £ 45.0944 CHF 49.6200
    30. Sept. 2026 £ 45.8378 CHF 51.1200
    29. Sept. 2026 £ 45.9697 CHF 50.8800
    28. Sept. 2026 £ 46.1799 CHF 51.2000

    Ausschüttungsverlauf

    Ausschüttungsfrequenz

    Vierteljährlich

    Ausschüttungsrendite 30. Sept. 2026

    3.15%

    TypeAusschüttung pro FondsanteilEx-Dividenden-TagStichtagAuszahlungsdatum
    Einkommen £ 0.3968 17. Sept. 2026 18. Sept. 2026 30. Sept. 2026
    Einkommen £ 0.4532 18. Juni 2026 19. Juni 2026 01. Juli 2026
    Einkommen £ 0.3620 19. März 2026 20. März 2026 01. Apr. 2026
    Einkommen £ 0.2297 18. Dez. 2025 19. Dez. 2025 31. Dez. 2025
    Einkommen £ 0.3641 18. Sept. 2025 19. Sept. 2025 01. Okt. 2025
    Einkommen £ 0.4017 19. Juni 2025 20. Juni 2025 02. Juli 2025
    Einkommen £ 0.3535 20. März 2025 21. März 2025 02. Apr. 2025
    Einkommen £ 0.2101 12. Dez. 2024 13. Dez. 2024 27. Dez. 2024
    Einkommen £ 0.3380 12. Sept. 2024 13. Sept. 2024 25. Sept. 2024
    Einkommen £ 0.5586 13. Juni 2024 14. Juni 2024 26. Juni 2024

    Der Wert von Anlagen und die daraus resultierenden Erträge können steigen oder fallen, und Investoren können Verluste auf ihre Investitionen erleiden.

    Purchase information

    Währungen und Börsen

    Währungen: GBP, CHF, EUR, MXN

    Basiswährung:GBP

    Börsen: London Stock Exchange, SIX Swiss Exchange, Deutsche Boerse, Bolsa Mexicana De Valores, Borsa Italiana S.p.A.

    Fondsticker

    Der Wert von Anlagen und die daraus resultierenden Erträge können steigen oder fallen, und Investoren können Verluste auf ihre Investitionen erleiden.

    SEDOL und SEDOL Masterfile® sind eingetragene Handelsmarken der London Stock Exchange Group PLC. SEDOL-Daten stammen von der SEDOL Masterfile® der London Stock Exchange.